FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology and anaesthesia, and may be used for anaesthetic care for surgical management of oncological patients with accompanied cardiovascular insufficiency. Before the operation, blood 200-250 ml is sampled from a median cubital vein into a blood transfusion container with the anticoagulant Glugicirum 49 ml. Then, the container is added with the complex preparation cytoflavin 0.16I0.02 ml/kg of body weight. After cytoflavin is incubated on autoblood at t -37C for 30 minutes, it is administered intravenously drop-by-drop immediately before the beginning of the anaesthetic care.
EFFECT: method provides improved quality of the anaesthetic care in such patients due to provided adequate correction of haemodynamics and related metabolic homeostatic disorders, prevented developing oxidative stress at all the operative stages, as well as ensured non-specific extra stimulation of the immune system.
1 tbl, 1 ex
